Chronic liver diseases: From development to novel pharmacological therapies: IUPHAR Review 37. (2023)
Attributed to:
MICA: Molecular drivers of fibrosis at the hepatic epithelial-mesenchymal barrier
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1111/bph.15853
PubMed Identifier: 35393658
Publication URI: http://europepmc.org/abstract/MED/35393658
Type: Journal Article/Review
Volume: 180
Parent Publication: British journal of pharmacology
Issue: 22
ISSN: 0007-1188